Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 11575

1.

Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Roohi-Azizi M, Arabzadeh S, Amidfar M, Salimi S, Zarindast MR, Talaei A, Akhondzadeh S.

Clin Neuropharmacol. 2017 Jan/Feb;40(1):1-5. doi: 10.1097/WNF.0000000000000185.

PMID:
28085707
2.

A review of trazodone use in psychiatric and medical conditions.

Khouzam HR.

Postgrad Med. 2017 Jan;129(1):140-148. doi: 10.1080/00325481.2017.1249265. Review.

PMID:
27744763
3.

The symptom trajectories to clinical remission in Chinese patients with unipolar major depressive disorder.

Cao Y, Shen J, Li W, Zhang Y, Guo X, Li CS, Zhang Y, Luo X.

Asia Pac Psychiatry. 2016 Dec;8(4):309-311. doi: 10.1111/appy.12240.

PMID:
27015764
4.

Suicidality and its determinants among Polish patients with epilepsy.

Bosak M, Turaj W, Dudek D, Siwek M, Szczudlik A.

Neurol Neurochir Pol. 2016 Nov - Dec;50(6):432-438. doi: 10.1016/j.pjnns.2016.07.009.

PMID:
27550747
5.

Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.

Steiner AJ, Boulos N, Mirocha J, Wright SM, Collison KL, IsHak WW.

Clin Neuropharmacol. 2017 Jan/Feb;40(1):16-23. doi: 10.1097/WNF.0000000000000190.

PMID:
27764051
6.

Prescribing patterns of psychotropic medications and clinical features in patients with major depressive disorder with and without comorbid dysthymia in China.

Feng Y, Sha S, Hu C, Wang G, Ungvari GS, Chiu HF, Ng CH, Si TM, Chen DF, Fang YR, Lu Z, Yang HC, Hu J, Chen ZY, Huang Y, Sun J, Wang XP, Li HC, Zhang JB, Xiang YT.

Asia Pac Psychiatry. 2017 Mar;9(1). doi: 10.1111/appy.12261.

PMID:
27759189
7.

Effects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan.

Cheng BH, Chen PC, Yang YH, Lee CP, Huang KE, Chen VC.

Medicine (Baltimore). 2016 Sep;95(36):e4655. doi: 10.1097/MD.0000000000004655.

8.

Association between depressive disorders and risk of breast cancer recurrence after curative surgery.

Chen SJ, Chang CH, Chen KC, Liu CY.

Medicine (Baltimore). 2016 Aug;95(33):e4547. doi: 10.1097/MD.0000000000004547.

9.

New use for an old drug: oral ketamine for treatment-resistant depression.

Swiatek KM, Jordan K, Coffman J.

BMJ Case Rep. 2016 Aug 3;2016. pii: bcr2016216088. doi: 10.1136/bcr-2016-216088.

PMID:
27489070
10.

Celery root extract as an inducer of mania induction in a patient on venlafaxine and St John's Wort.

Khalid Z, Osuagwu FC, Shah B, Roy N, Dillon JE, Bradley R.

Postgrad Med. 2016 Sep;128(7):682-3. doi: 10.1080/00325481.2016.1218263.

PMID:
27467225
11.

Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.

Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, Barrett B, Farrand PA, Gilbody S, Kuyken W, O'Mahen H, Watkins ER, Wright KA, Hollon SD, Reed N, Rhodes S, Fletcher E, Finning K.

Lancet. 2016 Aug 27;388(10047):871-80. doi: 10.1016/S0140-6736(16)31140-0.

12.

Development of a Typology of Antidepressant Users: The Role of Mental Health Disorders and Substance Use.

Perreault M, Toure el H, Fleury MJ, Beaulieu S, Caron J.

J Popul Ther Clin Pharmacol. 2016;23(1):e90-102.

PMID:
27309844
13.
14.

[Brittle bones caused by antidepressants?].

Starostzik C.

MMW Fortschr Med. 2016 Jun 9;158(11):20. doi: 10.1007/s15006-016-8352-4. German. No abstract available.

PMID:
27271391
15.

[Antidepressant-resistant depression and the bipolar spectrum -- diagnostic and therapeutic considerations].

Rihmer Z, Gonda X, Rihmer A, Döme P.

Psychiatr Hung. 2016;31(2):157-68. Review. Hungarian.

PMID:
27244871
16.

Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability.

Xu Y, Bai SJ, Lan XH, Qin B, Huang T, Xie P.

Braz J Med Biol Res. 2016 May 24;49(6). pii: S0100-879X2016000600704. doi: 10.1590/1414-431X20164806. Review.

17.

Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.

[No authors listed]

Prescrire Int. 2016 Apr;25(170):96-9. Review.

PMID:
27186622
18.

Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder.

Tomita T, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S, Nakamura K, Yasui-Furukori N.

Clin Neuropharmacol. 2016 May-Jun;39(3):135-9. doi: 10.1097/WNF.0000000000000146.

PMID:
27171569
19.

'In my life antidepressants have been…': a qualitative analysis of users' diverse experiences with antidepressants.

Gibson K, Cartwright C, Read J.

BMC Psychiatry. 2016 May 11;16:135. doi: 10.1186/s12888-016-0844-3.

20.

Psychotherapy effectiveness for major depression: a randomized trial in a Finnish community.

Saloheimo HP, Markowitz J, Saloheimo TH, Laitinen JJ, Sundell J, Huttunen MO, A Aro T, Mikkonen TN, O Katila H.

BMC Psychiatry. 2016 May 6;16:131. doi: 10.1186/s12888-016-0838-1.

Items per page

Supplemental Content

Loading ...
Support Center